These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


240 related items for PubMed ID: 18315548

  • 1. Apixaban, an oral, direct and highly selective factor Xa inhibitor: in vitro, antithrombotic and antihemostatic studies.
    Wong PC, Crain EJ, Xin B, Wexler RR, Lam PY, Pinto DJ, Luettgen JM, Knabb RM.
    J Thromb Haemost; 2008 May; 6(5):820-9. PubMed ID: 18315548
    [Abstract] [Full Text] [Related]

  • 2. Arterial antithrombotic and bleeding time effects of apixaban, a direct factor Xa inhibitor, in combination with antiplatelet therapy in rabbits.
    Wong PC, Watson CA, Crain EJ.
    J Thromb Haemost; 2008 Oct; 6(10):1736-41. PubMed ID: 18647224
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. In vitro and in vivo studies of the novel antithrombotic agent BAY 59-7939--an oral, direct Factor Xa inhibitor.
    Perzborn E, Strassburger J, Wilmen A, Pohlmann J, Roehrig S, Schlemmer KH, Straub A.
    J Thromb Haemost; 2005 Mar; 3(3):514-21. PubMed ID: 15748242
    [Abstract] [Full Text] [Related]

  • 6. Effect of the direct factor Xa inhibitor apixaban in rat models of thrombosis and hemostasis.
    Schumacher WA, Bostwick JS, Stewart AB, Steinbacher TE, Xin B, Wong PC.
    J Cardiovasc Pharmacol; 2010 Jun; 55(6):609-16. PubMed ID: 20224421
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Razaxaban, a direct factor Xa inhibitor, in combination with aspirin and/or clopidogrel improves low-dose antithrombotic activity without enhancing bleeding liability in rabbits.
    Wong PC, Crain EJ, Watson CA, Wexler RR, Lam PY, Quan ML, Knabb RM.
    J Thromb Thrombolysis; 2007 Aug; 24(1):43-51. PubMed ID: 17323133
    [Abstract] [Full Text] [Related]

  • 9. Apixaban, a direct factor Xa inhibitor, inhibits tissue-factor induced human platelet aggregation in vitro: comparison with direct inhibitors of factor VIIa, XIa and thrombin.
    Wong PC, Jiang X.
    Thromb Haemost; 2010 Aug; 104(2):302-10. PubMed ID: 20589316
    [Abstract] [Full Text] [Related]

  • 10. Antithrombotic and anticoagulant profiles of TAK-442, a novel factor Xa inhibitor, in a rabbit model of venous thrombosis.
    Kawamura M, Konishi N, Hiroe K, Shofuda K, Imaeda Y, Fujimoto T, Kubo K.
    J Cardiovasc Pharmacol; 2010 Aug; 56(2):156-61. PubMed ID: 20410831
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pre-clinical pharmacodynamic study of a novel oral factor Xa inhibitor zifaxaban.
    Qiu X, Wang W, Zhao Z, Sun S, Tang L.
    Eur J Pharmacol; 2018 Oct 05; 836():50-56. PubMed ID: 30125563
    [Abstract] [Full Text] [Related]

  • 16. DU-176b, a potent and orally active factor Xa inhibitor: in vitro and in vivo pharmacological profiles.
    Furugohri T, Isobe K, Honda Y, Kamisato-Matsumoto C, Sugiyama N, Nagahara T, Morishima Y, Shibano T.
    J Thromb Haemost; 2008 Sep 05; 6(9):1542-9. PubMed ID: 18624979
    [Abstract] [Full Text] [Related]

  • 17. Antithrombotic Effects of Combined PAR (Protease-Activated Receptor)-4 Antagonism and Factor Xa Inhibition.
    Meah MN, Raftis J, Wilson SJ, Perera V, Garonzik SM, Murthy B, Everlof JG, Aronson R, Luettgen J, Newby DE.
    Arterioscler Thromb Vasc Biol; 2020 Nov 05; 40(11):2678-2685. PubMed ID: 32907366
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.